- GoodRx (GDRX, Financial) will release its Q1 2025 earnings on May 7, 2025, after U.S. markets close.
- The conference call is scheduled for May 8, 2025, at 5:00 a.m. PT (8:00 a.m. ET).
- Webcast of the earnings call will be accessible for at least 30 days on the GoodRx investor relations website.
GoodRx Holdings, Inc. (GDRX), a leader in medication savings in the U.S., has announced the release of its first quarter 2025 financial results. The results will be made available after the close of the U.S. markets on Wednesday, May 7, 2025.
A conference call and webcast with GoodRx management are scheduled for the following morning on Thursday, May 8, 2025, at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time). During the call, the management will discuss the quarterly results and the company's business outlook. Interested parties are encouraged to pre-register to get the necessary dial-in details and a unique passcode for participating in the call.
The conference call will be webcast live on GoodRx's investor relations website, where the related presentation materials will be accessible before the conference. An archived version of the webcast will be available for at least 30 days post the call, providing ample opportunity for stakeholders to access the recorded presentation.
GoodRx has consistently played a pivotal role in the U.S. healthcare system, helping consumers save on medications. Since its inception in 2011, the company has saved Americans over $85 billion in prescription costs.
For more information, investors and interested parties can visit GoodRx's investor relations website at https://investors.goodrx.com.
